Last reviewed · How we verify

NCT04011696: MERoV

Monofocal Extended Range of Vision (MERoV) Study

Completed Last updated 3 November 2023
What this trial tests

trial in Pseudophakia in 412 participants. Completed in 31 May 2022.

Timeline
3 July 2019
Primary endpoint
31 May 2022
31 May 2022

Quick facts

Lead sponsorBrighton and Sussex University Hospitals NHS Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment412
Start date3 July 2019
Primary completion31 May 2022
Estimated completion31 May 2022
Sites1 location across United Kingdom

Conditions studied

Sponsor

Brighton and Sussex University Hospitals NHS Trust

Who can join

18 and older, any sex, with Pseudophakia or Accomodation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are proposing this research project to: 1. Screen a set of patients after normal cataract surgery with a single focus lens aimed at good distance vision at 3 months after surgery to identify patients who are able to see and read well without glasses. 2. Identify the combination of factors responsible for this phenomenon in the patients who are achieving this. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. At 3 months after surgery they will have their un-corrected vision checked. They will also have their reading speed assessed without any glasses. They will undergo a through refractive check by an optometrist to assess the power of the spectacles (if needed) and following this they will have a scan of the eye (a technique known as wave front analysis which uses very sophisticated optics) to capture the optical distortions in the structures of the eye. If this study is able identify factor/s responsible for giving good unaided reading and distance vision then this factor can be reproduced in eyes undergoing cataract surgery. This will mean that the patients can have an increased option of spectacle independence without the need for expensive multifocal IOLs and their associated side effects such as glare and halos, particularly at night.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Incidence and factors for pseudoaccommodation after monofocal lens implantation: the Monofocal Extended Range of Vision study.
    Nanavaty MA, Mukhija R, Ashena Z, Bunce C, et al · · 2023 · cited 9× · PMID 37769187 · DOI 10.1097/j.jcrs.0000000000001302
  2. Unaided reading speed in pseudophakic patients after emmetropic monofocal intraocular lens implantation.
    Nanavaty MA, Mukhija R, Ashena Z, Bunce C, et al · · 2025 · PMID 41131330 · DOI 10.1038/s41433-025-04048-x

Verify or expand the search:

Other recruiting trials for Pseudophakia

Currently open trials in the same condition.

Other Brighton and Sussex University Hospitals NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04011696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing